Betamethasone Dipropionate Ointment, Augmented
Product Images NDC 0472-0382

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 0472-0382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Struct (Image 1)

Chemical structure diagram of betamethasone dipropionate showing its steroid backbone with fluorine, hydroxyl, ketone, and ester functional groups represented by standard chemical bonds and atomic symbols.*

FDA Label Image

Image (Image 2)

Packaging label for Betamethasone Dipropionate ointment USP Augmented, 0.05% (0.5 mg/g) strength by Actavis Mid Atlantic LLC. The label indicates a 15 g (0.53 oz) tube, for topical use only, not for oral, ophthalmic, or intravaginal use. Includes dosage and storage instructions, NDC 0472-0382-15, and tamper-evident seal information.*

FDA Label Image

Image (Image 3)

Box packaging label for Betamethasone Dipropionate Ointment USP (Augmented) 0.05% strength, 15 grams (0.53 oz) tube. Labeler is Actavis Mid Atlantic LLC. Indicated for topical use only, not for oral, ophthalmic, or intravaginal use. The NDC code 0472-0382-15 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.